Voglilarm G 2mg/500mg/0.2mg Tablet
Marketer
Larion Life Sciences Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Voglilarm G 2mg/500mg/0.2mg Tablet
Diabetic patients using the combined medication, Glargil 2mg/500mg/0.2mg tablets, should understand its anti-diabetic properties. This triple-action formulation is indicated for adult type 2 diabetes mellitus management, effectively regulating blood glucose. Always take this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continuous use is crucial, even with controlled blood sugar; abrupt cessation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is just one component of a comprehensive diabetes management plan, which includes dietary changes, regular physical activity, and weight management as directed by your doctor. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms, such as sweating, dizziness, headache, and tremors, and know how to counteract them. Maintain regular mealtimes and always carry a fast-acting glucose source like sugary snacks or juice. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Its suitability for pregnant or breastfeeding women requires prior medical consultation. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function as advised by your doctor.
Uses of Voglilarm G 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Voglilarm G 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Voglilarm G 2mg/500mg/0.2mg Tablets. Ingest the tablets whole; do not break, crush, or chew them. Administer on an empty stomach.
Common Side effects of Voglilarm G 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglilarm G 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Voglilarm G 2mg/500mg/0.2mg Tablets. Ingest the tablets whole; do not chew, crush, or divide them. Administer on an empty stomach.
How Voglilarm G 2mg/500mg/0.2mg Tablet works:
Each Voglilarm G tablet (2mg/500mg/0.2mg) contains a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglilarm G 2mg/500mg/0.2mg Tablet with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Voglilarm G 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Use of Voglilarm G 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Voglilarm G 2mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Voglilarm G 2mg/500mg/0.2mg Tablets is discouraged in those with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Voglilarm G 2mg/500mg/0.2mg tablets cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should typically begin with a reduced dosage; however, its use is contraindicated in those with severe hepatic dysfunction. Physician consultation is advised.
What if you forget to take Voglilarm G 2mg/500mg/0.2mg Tablet :
Should you forget to take your Voglilarm G 2mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglilarm G 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently